WhatsApp Group Join Now
WhatsApp Channel Join Now
Telegram Group Join Now
HomeAndhra PradeshLyfius Pharma (Aurobindo) walk-in interview for Freshers on 20th June 2024

Lyfius Pharma (Aurobindo) walk-in interview for Freshers on 20th June 2024

Greetings from Aurobindo Pharma Limited – API Division. We are currently seeking Fresh Graduates to join our team at Lyfius Pharma Private Limited, a subsidiary of Aurobindo Pharma Limited, for our Greenfield projects in Kakinada, Andhra Pradesh, India. If you are interested and meet the eligibility criteria, please attend the recruitment drive scheduled on 20-06-2024 at Surampalem, Kakinada.

Engineering & Projects

Qualification: Diploma / B.Tech – (Mechanical)
Experience: Fresher (0 yrs to 01 yrs) or Relevant experience in Engineering or Projects.

Fermentation – Production

Qualification: M.Sc/B.Tech (Biotechnology)
Experience: Fresher (0 yrs to 01 yrs) or Relevant experience in Fermentation production

Extraction- Production

Qualification: Diploma/B.Tech (Chemical)
Experience: Fresher (0 yrs to 01 yrs) or Relevant experience in Chemical Manufacturing.

THE WALK-IN DRIVE WILL BE HELD ON:
DAY & DATE: THURSDAY & 20 JUNE 2024
START AT: 09:00 AM – 05:00 PM
VENUE: ADITYA EDUCATIONAL INSTITUTIONS, ADB ROAD, ADITYA NAGAR, SURAMPALEM, ANDHRA PREDESH.

Please Note:
Lyfius Pharma Private Limited does not directly or indirectly charge any fees for job application or processing. Do not participate in any such invitations.
KINDLY BRING 2 COPIES OF UPDATED RESUME, PASSPORT SIZE PHOTO, EDUCATIONAL DOCUMENTS & IF ANY PAYSLIPS.

Lyfius Pharma (Aurobindo) walk-in interview for Freshers on 20th June 2024

1/5 (1 Review)

Discover more from Pharma Walks

Subscribe to get the latest posts sent to your email.

RELATED JOBS

Join us

3,654FansLike
5,353FollowersFollow
4,233FollowersFollow
9,843SubscribersSubscribe

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Discover more from Pharma Walks

Subscribe now to keep reading and get access to the full archive.

Continue reading